Skip to main content
. 2022 Feb 2;4(5):100445. doi: 10.1016/j.jhepr.2022.100445

Fig. 4.

Fig. 4

Cumulative survival curves in the validation cohort according to R3-AFP score categories.

R3-AFP, recurrence risk reassessment–alpha-foetoprotein.